Your browser doesn't support javascript.
loading
Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial.
Binkley, N; Bone, H; Gilligan, J P; Krause, D S.
Affiliation
  • Binkley N; University of Wisconsin Osteoporosis Clinical Center and Research Program, Madison, WI, USA, nbinkley@wisc.edu.
Osteoporos Int ; 25(11): 2649-56, 2014 Nov.
Article in En | MEDLINE | ID: mdl-25027109
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcitonin / Bone Density / Osteoporosis, Postmenopausal / Bone Density Conservation Agents / Osteoporotic Fractures Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2014 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcitonin / Bone Density / Osteoporosis, Postmenopausal / Bone Density Conservation Agents / Osteoporotic Fractures Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2014 Document type: Article Country of publication: